SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Therapeutic Advances in Respiratory Disease
This Article
Right arrow Abstract Freely available
Right arrow Free Full Text (Free PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Miravitlles, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Miravitlles, M.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Reviews

Review: Do we need new antibiotics for treating exacerbations of COPD?

Marc Miravitlles, MD

Servei de Pneumologia Hospital Clínic, UVIR (esc 2, planta 3), Villarroel 170, 08036 Barcelona, Spain marcm{at}clinic.ub.es

Exacerbations may produce permanent impairment in lung function and health status in patients with COPD. Up to 70% of episodes have a bacterial etiology, being of mixed viral infection in some cases. The new, more active antibiotics have demonstrated better eradication of bacteria in the airways and, consequently, prolongation of the time to the next exacerbation. However, the ability of bacteria to develop resistance to the antibiotics currently used warrants novel research into new families of antimicrobials, and the adoption of new strategies such as the prevention of exacerbations, nebulized antibiotic treatment or the use of antibiotics in combination.

Key Words: COPD • chronic bronchitis • infection • colonization • bacteria • exacerbations. Introduction

References

  • Aaron, S.D. et al. (2002) Measurment of short-term changes in dyspnoea and disease-specific quality of life following an acute COPD exacerbation. Chest 121: 688—696.[CrossRef][Medline] [Order article via Infotrieve]
  • Adams, S.G. et al. (2000) Antibiotics are associated with lower relapse rates in outpatients with acute exacerbations of COPD. Chest 117: 1345—1352.[CrossRef][Medline] [Order article via Infotrieve]
  • Alat (2001) Grupo de Trabajo de la Asociación Latinoamericana del Tórax. Recomendaciones ALAT sobre exacerbación infecciosa de la EPOC. Arch Bronconeumol 37: 349—357.[Medline] [Order article via Infotrieve]
  • ALAT work group (2004) Update to the Latin American Thoracic Society (ALAT) recommendations on infectous exacerbations of COPD. Arch Bronconeumol 40: 315—325.[CrossRef][Medline] [Order article via Infotrieve]
  • Allegra, L. et al. (1991) Ruolo degli antibiotici nel trattamento delle riacutizzazioni della bronchite cronica: risultati di uno studio italiano multicentrico. Ital J Chest Dis 45: 138—148.
  • Alvarez-Mon, M. et al. (2005) Treatment with the immunomodulator AM3 (Inmunoferon) improves the health-related quality of life of patients with chronic obstructive pulmonary disease. Chest 127: 1212—1218.[CrossRef][Medline] [Order article via Infotrieve]
  • Anthonisen, N.R. et al. (1987) Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med 106: 196—204.[Abstract/Free Full Text]
  • Austrian, R. and Gold, J. (1964) Pneumococcal bacteremia with special reference to bacteremic pneumococcal pneumonia. Ann Intenr Med 60: 759—776.
  • Balgos, A.A. (1998). Guidelinies for the role of antibiotics in acute exacerbations of chronic bronchitis in the Asia-Pacific region: report and recommendations of a consensus group. Med Progress 25: 29—38.
  • Ball, P. and Wilson, R. (1995) The epidemiology and management of chronic bronchitis, the Cinderella of chest diseases: epidemiology and management of chronic bronchitis: a selection of classic papers. Worthing, England: Cambridge Medical Publications, 1995.
  • Ball, P. et al. (1995) Acute infective exacerbations of chronic bronchitis. Quant J Med 88: 61—68.
  • Balter, M.S. et al. (1994) Recommendations on the management of chronic bronchitis. A practical guide for Canadian physicians. Can Med Ass J 151(Suppl): 7—23.
  • Balter, M.S. et al. (2003) Canadian guidelines for the management of acute exacerbations of chronic bronchitis. Can Respir J 10 (Suppl B): 3B—32B.[Medline] [Order article via Infotrieve]
  • Bandi, V. et al. (2001) Nontypeable Haemophilus influenzae in the lower respiratory tract of patients with chronic bronchitis. Am J Respir Crit Care Med 164: 2114—2119.[Abstract/Free Full Text]
  • Blasi, F. et al. (2002) Chlamydia pneumoniae and chronic bronchitis: association with severity and bacterial clearance after treatment. Thorax 57: 672—676.[Abstract/Free Full Text]
  • Bresser, P. et al. (1997) Persisting Haemophilus influenzae strains induce lower levels of interleukin-6 and interleukin-8 in H292 lung epithelial cells than nonpersisting strains. Eur Respir J 10: 2319—2326.[Abstract]
  • Bresser, P. et al. (2000) Airway inflammation in nonobstructive and obstructive chronic bronchitis with chronic Haemophilus influenzae airway infection. Am J Respir Crit Care Med 162: 947—952.[Abstract/Free Full Text]
  • Burrows, B. and Earle, R.H.( 1969) Course and prognosis of chronic obstructive lung disease: a prospective study of 200 patients. New Engl J Med 280: 397—404.[Medline] [Order article via Infotrieve]
  • Chodosh, S. et al. (1998) The efficacy of oral ciprofloxacin vs. clarithromycin for the treatment of acute bacterial exacerbations of chronic bronchitis. Clin Infect Dis 27: 730—738.[Medline] [Order article via Infotrieve]
  • Chodosh, S. et al. (2000) Short-course moxifloxacin therapy for treatment of acute bacterial exacerbations of chronic bronchitis. Respir Med 94: 18—27.[CrossRef][Medline] [Order article via Infotrieve]
  • Cole, P. and Wilson, R. (1989) Host-microbial interrelationships in respiratory infection. Chest 95: 17S—21S.
  • Connors Jr, A.F. et al. (1996) Outcomes following acute exacerbation of severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med 154: 959—967.[Abstract]
  • Crooks, S.W. et al. (2000) Bronchial inflammation in acute bacterial exacerbations of chronic bronchitis: the role of leukotriene B4. Eur Respir J 15: 274—280.[Abstract]
  • DeAbate, C.A. et al. (1998) Sparfloxacin vs ofloxacin in the treatment of acute bacterial exacerbations of chronic bronchitis. A multicenter, double-blind, randomized, comparative study. Chest 114: 120—130.[Medline] [Order article via Infotrieve]
  • Decramer, M. et al. (2005) Effects of N-acetylcysteine on outcomes in chronic obstructive pulmonary disease (Bronchitis Randomized on NAC Cost-Utility Study, BRONCUS): a randomized placebo-controlled trial. Lancet 365: 1552—1560.[CrossRef][Medline] [Order article via Infotrieve]
  • Dewan, N.A. et al. (2000) Acute exacerbation of COPD. Factors associated with poor outcome. Chest 117: 662—671.[CrossRef][Medline] [Order article via Infotrieve]
  • Doll, H. and Miravitlles, M. (2005) Quality of life in acute exacerbations of chronic bronchitis and chronic obstructive pulmonary disease: A review of the literature. Pharmacoeconomics 23: 345—363.[CrossRef][Medline] [Order article via Infotrieve]
  • Donaldson, G.C. et al. (2002) Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax 57: 847—852.[Abstract/Free Full Text]
  • Eller, J. et al. (1998) Infective exacerbations of chronic bronchitis. Relation between bacteriologic etiology and lung function. Chest 113: 1542—1548.[CrossRef][Medline] [Order article via Infotrieve]
  • Evans, A.T. et al. (2002) Azithromycin for acute bronchitis: a randomized, double-blind, controlled trial. Lancet 359: 1648—1654.[CrossRef][Medline] [Order article via Infotrieve]
  • Gompertz, S. et al. (2001) Changes in bronchial inflammation during acute exacerbations of chronic bronchitis. Eur Respir J 17: 1112—1119.[Abstract/Free Full Text]
  • Gottlieb, D.J. et al. (1996) Urinary desmosine excretion in smokers with and without rapid decline of lung function. The Normative Aging Study. Am J Respir Crit Care Med 154: 1290—1295.[Abstract]
  • Grossman, R. et al. (1998) A 1-year community-based health economic study of ciprofloxacin vs usual antibiotic treatment in acute exacerbations of chronic bronchitis. Chest 113: 131—141.[Medline] [Order article via Infotrieve]
  • Hill, A.T. et al. (2000) Association between airway bacterial load and markers of airway inflammation in patients with stable chronic bronchitis. Am J Med 109: 288—295.[CrossRef][Medline] [Order article via Infotrieve]
  • Jemal, A. et al. (2005) Trends in the leading causes of death in the United States, 1970—2002. J Am Med Assoc 294: 1255—1259.[Abstract/Free Full Text]
  • Kanner, R.E. et al. (2001) Lower respiratory illnesses promote FEV1 decline in current smokers but not ex-smokers with mild chronic obstructive pulmonary disease. Am J Respir Crit Care Med 164: 358—364.[Abstract/Free Full Text]
  • Kessler, R. et al. (1999) Predictive factors of hospitalization for acute exacerbation in a series of 64 patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 159: 158—164.[Abstract/Free Full Text]
  • Kosmas, E.N. et al. (1997) Decreased C4 complement component serum levels correlate with the degree of emphysema in patients with chronic bronchitis. Chest 112: 341—347.[Medline] [Order article via Infotrieve]
  • Lode, H. et al. (2004) Levofloxacin versus clarithromycin in COPD exacerbation: focus on infection-free interval. Eur Respir J 24: 947—953.[Abstract/Free Full Text]
  • MacFarlane, J.T. et al. (1993) Prospective study of aetiology and outcome of adult lower respiratory tract infections in the community. Lancet 341: 511—514.[CrossRef][Medline] [Order article via Infotrieve]
  • Mannino, D.M. et al. (1997) Obstructive lung disease deaths in the United States from 1979 through 1993. An analysis using multiplecause mortality data. Am J Respir Crit Care Med 156: 814—818.[Abstract/Free Full Text]
  • Mio, T. et al. (1997) Cigarette smoke induces interleukin-8 release from human bronchial epithelial cells. Am J Respir Crit Care Med 155: 1770—1776.[Abstract]
  • Miravitlles, M. (2002a) Epidemiology of chronic obstructive pulmonary disease exacerbations. Clin Pulm Med 9: 191—197.[CrossRef]
  • Miravitlles, M. (2002b) Exacerbations of chronic obstructive pulmonary disease: when are bacteria important? Eur Respir J 20 (Suppl 36): 9s—19s.
  • Miravitlles, M. (2005) Health status and costs of exacerbations of chronic bronchitis and COPD: how to improve antibiotic treatment. Expert Rev Pharmacoeconomics Outcomes Res 5: 423—435.[CrossRef]
  • Miravitlles, M. and Morera, J. (2007) It's time for an etiology-based definition of chronic obstructive pulmonary disease. Respirology 12: 317—319.[CrossRef][Medline] [Order article via Infotrieve]
  • Miravitlles, M. and Torres, A. (2004a) Antibiotics in exacerbations of COPD: lessons from the past. Eur Respir J 24: 896—897.[Free Full Text]
  • Miravitlles, M. and Torres, A. (2004b) No more equivalence trials for antibiotics in exacerbations of COPD, please. Chest 125: 811—813.[CrossRef][Medline] [Order article via Infotrieve]
  • Miravitlles, M. et al. (1999) Relationship between bacterial flora in sputum and functional impairment in patients with acute exacerbations of COPD. Chest 116: 40—46.[CrossRef][Medline] [Order article via Infotrieve]
  • Miravitlles, M. et al. (2001) Factors associated with relapse after ambulatory treatment of acute exacerbations of chronic bronchitis. A prospective multicenter study in the community. Eur Respir J 17: 928—933.[Abstract/Free Full Text]
  • Miravitlles, M. et al. (2002) Pharmacoeconomic evaluation of acute exacerbations of chronic bronchitis and COPD. Chest 121: 1449—1455.[CrossRef][Medline] [Order article via Infotrieve]
  • Miravitlles, M. et al. (2003) Pharmacoeconomic study of antibiotic therapy for acute exacerbations of chronic bronchitis and chronic obstructive pulmonary disease. Arch Bronconeumol 39: 549—553.[CrossRef][Medline] [Order article via Infotrieve]
  • Miravitlles, M. et al. (2004a) Exacerbations impair quality of life in patients with chronic obstructive pulmonary disease. A two-year follow-up study. Thorax 59: 387—395.[Abstract/Free Full Text]
  • Miravitlles, M. et al. (2004b) The effect of various antimicrobial regimens on the clinical course of exacerbations of chronic bronchitis and chronic obstructive pulmonary disease in primary care. Clin Drug Invest 24: 63—72.[CrossRef]
  • Miravitlles, M. et al. (2007) Patient's perception of exacerbations of COPD — the PERCEIVE study. Respir Med 101: 453—460.[CrossRef][Medline] [Order article via Infotrieve]
  • Mogulkoc, N. et al. (1999) Acute purulent exacerbation of chronic obstructive pulmonary disease and Chlamydia pneumoniae infection. Am J Respir Crit Care Med 160: 349—353.[Abstract/Free Full Text]
  • Möller, L.V.M. et al. (1998) Haemophilus influenzae in lung explants of patients with end-stage pulmonary disease. Am J Respir Crit Care Med 157: 950—956.[Abstract/Free Full Text]
  • Monsó, E. et al. (1995) Bacterial infection in chronic obstructive pulmonary disease. A study of stable and exacerbated outpatients using the protected specimen brush. Am J Respir Crit Care Med 152: 1316—1320.[Abstract]
  • Monsó, E. et al. (1999) Risk factors for lower airway bacterial colonization in chronic bronchitis. Eur Respir J 13: 338—342.[Abstract]
  • Nouira, S. et al. (2001) Once daily oral ofloxacin in chronic obstructive pulmonary disease exacerbation requiring mechanical ventilation: a randomized placebo-controlled trial. Lancet 358: 2020—2025.[CrossRef][Medline] [Order article via Infotrieve]
  • Papi, A. et al. (2006) Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations. Am J Respir Crit Care Med 173: 1114—1121.[Abstract/Free Full Text]
  • Patel, I.S. (2002) Relationship between bacterial colonization and the frequency, character, and severity of COPD exacerbations. Thorax 57: 759—764.[Abstract/Free Full Text]
  • Poole, P.J. and Black, P.N. (2001) Oral mucolytic drugs for exacerbations of chronic obstructive pulmonary disease: systematic review. Br Med J 322: 1—6.[Free Full Text]
  • Prieto, A. et al. (2001) Defective natural killer and phagocytic activities in chronic obstructive pulmonary disease are restored by glycophosphopeptical (Inmunoferon). Am J Respir Crit Care Med 163: 1578—1583.[Abstract/Free Full Text]
  • Puhan, M.A. et al. (2007) Exacerbations of chronic obstructive pulmonary disease: When are antibiotics indicated? A systematic review. Respir Res 8: 8—30.[CrossRef][Medline] [Order article via Infotrieve]
  • Ras, G. et al. (1990) The effect of bacterial products on neutrophil migration in vitro. Thorax 45: 276—280.[Abstract/Free Full Text]
  • Rohde, G. et al. (2003) Respiratory viruses in exacerbations of chronic obstructive pulmonary disease requiring hospitalization: a case-control study. Thorax 58: 37—42.[Abstract/Free Full Text]
  • Sachs, A.P.E. et al. (1995) Changes in symptoms, peak expiratory flow, and sputum flora during treatment with antibiotics of exacerbations in patients with chronic obstructive pulmonary disease in general practice. Thorax 50: 758—763.[Abstract/Free Full Text]
  • Saint, S. et al. (1995) Antibiotics in chronic obstructive pulmonary disease exacerbations: a meta-analysis. J Am Med Assoc 273: 957—960.[Abstract/Free Full Text]
  • Scott, S. et al. (2006) COPD exacerbations. 4: Prevention. Thorax 61: 440—447.[Abstract/Free Full Text]
  • Seemungal, T.A.R. (2000) Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 161: 1608—1613.[Abstract/Free Full Text]
  • Seemungal, T.A.R. et al. (1998) Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 157: 1418—1422.[Medline] [Order article via Infotrieve]
  • Seemungal, T.A.R. et al. (2000) Detection of rhinovirus in induced sputum at exacerbation of chronic obstructive pulmonary disease. Eur Respir J 16: 677—683.[Abstract]
  • Seemungal, T. et al. (2001) Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease. Am J Respir Crit Care Med 164: 1618—1623.[Abstract/Free Full Text]
  • Sethi, S. (2002) New strains of bacteria and exacerbations of chronic obstructive pulmonary disease. N Engl J Med 347: 465—471.[Abstract/Free Full Text]
  • Sethi, S. (2007) Airway bacterial concentrations and exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2007. Published ahead of print doi: 10.1164/rccm.200703—417OC.
  • Sobradillo, V. et al. (2000) Geographical variations in prevalence and underdiagnosis of COPD. Results of the IBERPOC multicentre epidemiological study. Chest 118: 981—989.[CrossRef][Medline] [Order article via Infotrieve]
  • Soler, N. et al. (1999) Airway inflammation and bronchial microbial patterns in patients with stable chronic obstructive pulmonary disease. Eur Respir J 14: 1015—1022.[Abstract]
  • Soler, N. et al. (1998) Bronchial microbial patterns in severe exacerbations of chronic obstructive pulmonary disease (COPD) requiring mechanical ventilation. Am J Respir Crit Care Med 157: 1498—1505.[Medline] [Order article via Infotrieve]
  • Soler, N. et al. (2007) Bronchoscopic validation of the significance of sputum purulence in severe exacerbations of chronic obstructive pulmonary disease. Thorax 62: 29—35.[Abstract/Free Full Text]
  • Spencer, S. and Jones, P.W. (2003) Time course of recovery of health status following an infective exacerbation of chronic bronchitis. Thorax 58: 589—593.[Abstract/Free Full Text]
  • Stanescu, D. et al. (1996) Airways obstruction, chronic expectoration, and rapid decline of FEV1 in smokers are associated with increased levels of sputum neutrophilia. Thorax 51: 267—271.[Abstract/Free Full Text]
  • Stockley, R.A. et al. (2000) Relationship of sputum color to nature and outpatient management of acute exacerbations of COPD. Chest 117: 1638—1645.[CrossRef][Medline] [Order article via Infotrieve]
  • Viglio, S. et al. (2000) MEKC of desmosine and isodesmosine in urine of chronic destructive lung disease patients. Eur Respir J 15: 1039—1045.[Abstract]
  • White, A.J. et al. (2003) Resolution of bronchial inflammation is related to bacterial eradication following treatment of exacerbations of chronic bronchitis. Thorax 58: 680—685.[Abstract/Free Full Text]
  • Wilkinson, T.M.A. et al. (2003) Airway bacterial load and FEV1 decline in patients with chronic obstructive pulmonay disease. Am J Respir Crit Care Med 167: 1090—1095.[Abstract/Free Full Text]
  • Wilson, R. (2001) Bacteria, antibiotics and COPD. Eur Respir J 17: 995—1007.[Abstract/Free Full Text]
  • Wilson, R. et al. (1999) Five day moxifloxacin therapy compared with 7 day clarithromycin therapy for the treatment of acute exacerbations of chronic bronchitis. J Antimicrob Chemother 44: 501—513.[Abstract/Free Full Text]
  • Wilson, R. et al. (2002) A comparison of gemifloxacin and clarithromycin in acute exacerbations of chronic bronchitis and long-term clinical outcomes. Clin Ther 24: 639—652.[CrossRef][Medline] [Order article via Infotrieve]
  • Wilson, R. et al. (2004) Short and long-term outcomes of moxifloxacin compared to standard antibiotic treatment in acute exacerbations of chronic bronchitis. Chest 125: 953—964.[CrossRef][Medline] [Order article via Infotrieve]
  • Wu, L. et al. (2000) Immunohistochemical staining for Chlamydia pneumoniae is increased in lung tissue from subjects with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 162: 1148—1151.[Abstract/Free Full Text]
  • Zalacain, R. et al. (1999) Predisposing factors to bacterial colonization in chronic obstructive pulmonary disease. Eur Respir J 13: 343—348.[Abstract]

Therapeutic Advances in Respiratory Disease, Vol. 1, No. 1, 61-76 (2007)
DOI: 10.1177/1753465807082692
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?



This Article
Right arrow Abstract Freely available
Right arrow Free Full Text (Free PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Miravitlles, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Miravitlles, M.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Advertisement